Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA32712
Max Phase: Preclinical
Molecular Formula: C23H29NaO7
Molecular Weight: 418.49
Molecule Type: Small molecule
Associated Items:
ID: ALA32712
Max Phase: Preclinical
Molecular Formula: C23H29NaO7
Molecular Weight: 418.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CCC2C(C)(C)[C@H](O)[C@H](O)C[C@]2(C)[C@@]12Cc1c(O)cc(C(=O)[O-])c(C=O)c1O2.[Na+]
Standard InChI: InChI=1S/C23H30O7.Na/c1-11-5-6-17-21(2,3)19(27)16(26)9-22(17,4)23(11)8-13-15(25)7-12(20(28)29)14(10-24)18(13)30-23;/h7,10-11,16-17,19,25-27H,5-6,8-9H2,1-4H3,(H,28,29);/q;+1/p-1/t11-,16-,17?,19-,22+,23-;/m1./s1
Standard InChI Key: FKIBNJKXUZPWHY-GVJFPPMBSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 418.49 | Molecular Weight (Monoisotopic): 418.1992 | AlogP: 2.78 | #Rotatable Bonds: 2 |
Polar Surface Area: 124.29 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.88 | CX Basic pKa: | CX LogP: 2.75 | CX LogD: -0.69 |
Aromatic Rings: 1 | Heavy Atoms: 30 | QED Weighted: 0.54 | Np Likeness Score: 2.70 |
1. Kaufman TS, Srivastava RP, Sindelar RD, Scesney SM, Marsh HC.. (1995) Design, synthesis, and evaluation of A/C/D-ring analogs of the fungal metabolite K-76 as potential complement inhibitors., 38 (9): [PMID:7739002] [10.1021/jm00009a004] |
2. Srivastava RP, Xiaoyan Zhu, Walker LA, Sindelar RD. (1995) Design, synthesis and evaluation of C/D-ring analogs of the fungal metabolite K-76 as potential complement inhibitors, 5 (15): [10.1016/0960-894X(95)00267-W] |
3. Srivastava RP, Zhu X, Walker LA, Sindelar RD. (1995) Further structure-activity-relationship studies on A/C/D-ring analogs of complement inhibitor K-76, 5 (20): [10.1016/0960-894X(95)00423-Q] |
4. Kaufman TS, Srivastava RP, Sindelar RD, Scesney SM, Marsh HC. (1995) The design, synthesis and evaluation of A,C,D-ring analogs of the fungal metabolite K-76 as complement inhibitors: a potential probe for the absolute stereochemistry at position 2, 5 (5): [10.1016/0960-894X(95)00061-W] |
5. Useglio M, Castellano PM, Operto MA, Torres R, Kaufman TS.. (2006) Synthesis of 3H-spiro[benzofuran-2,1'-cyclohexane] derivatives from naturally occurring filifolinol and their classical complement pathway inhibitory activity., 16 (19): [PMID:16875818] [10.1016/j.bmcl.2006.07.029] |
Source(1):